News Center

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

The dean of the University of Maryland School of Pharmacy has formed a Diversity, Equity, and Inclusion (DEI) Task Force to guide the development of concrete plans to ensure that the School is welcoming, inclusive, and representative of everyone in its community.

Presentations from School leadership and program faculty help set expectations for Doctor of Pharmacy (PharmD) and graduate students during this unprecedented time.

Dr. Sandeep Devabhakthuni will lead the organization in its mission to improve patient outcomes by promoting optimal medication use, professional development, and public health in health-systems.

Virtual ceremony honors the program’s 44 graduates as they prepare to take the next step in their careers improving quality of life for patients impacts by serious illness.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

Presentations from academic institutions and health care systems across the United States shared best practices and strategies to support the continued advancement of patient-centered outcomes research.

Experts in geriatric pharmacotherapy and substance use research explore current methods for managing chronic pain in older adults, including potential areas of improvement in patient care and policy.

Online webinar featuring presentations from the School’s leadership and faculty helps put members of the Class of 2024 on the path to success in their first year of pharmacy school.

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Natalie D. Eddington, PhD, FAAPS, FCP, dean and professor of the School of Pharmacy, issues statement on the death of George Floyd and ongoing racial and social injustices in the United States.